These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1249 related articles for article (PubMed ID: 33978330)

  • 61. Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivors.
    Fernández-de-Las-Peñas C; Ryan-Murua P; de-la-Llave-Rincón AI; Gómez-Mayordomo V; Arendt-Nielsen L; Torres-Macho J
    Pain; 2022 Nov; 163(11):2112-2117. PubMed ID: 35121694
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Visual classification of three computed tomography lung patterns to predict prognosis of COVID-19: a retrospective study.
    Yamada D; Ohde S; Imai R; Ikejima K; Matsusako M; Kurihara Y
    BMC Pulm Med; 2022 Jan; 22(1):1. PubMed ID: 34980061
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical characteristics of adult patients hospitalized with laboratory-confirmed COVID-19 pneumonia.
    Altunok ES; Alkan M; Kamat S; Demirok B; Satici C; Demirkol MA; Gursoy B; Surmeli CD; Cengel F; Calik M; Turkmen UA
    J Infect Chemother; 2021 Feb; 27(2):306-311. PubMed ID: 33191111
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

  • 65. National early warning score on admission as risk factor for invasive mechanical ventilation in COVID-19 patients: A STROBE-compliant study.
    Chang MC; Kim TU; Park D
    Medicine (Baltimore); 2021 May; 100(19):e25917. PubMed ID: 34106657
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Course and Risk Factors of Disease Deterioration in Critically Ill Patients with COVID-19.
    Qin W; Bai W; Liu K; Liu Y; Meng X; Zhang K; Zhang M
    Hum Gene Ther; 2021 Mar; 32(5-6):310-315. PubMed ID: 33412996
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir.
    Rahmani H; Davoudi-Monfared E; Nourian A; Nabiee M; Sadeghi S; Khalili H; Abbasian L; Ghiasvand F; Seifi A; Hasannezhad M; Ghaderkhani S; Mohammadi M; Yekaninejad MS
    Daru; 2020 Dec; 28(2):625-634. PubMed ID: 32857301
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19.
    Dong X; Sun L; Li Y
    Int J Med Sci; 2020; 17(14):2225-2231. PubMed ID: 32922185
    [No Abstract]   [Full Text] [Related]  

  • 69. Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.
    Kalligeros M; Shehadeh F; Atalla E; Mylona EK; Aung S; Pandita A; Larkin J; Sanchez M; Touzard-Romo F; Brotherton A; Shah R; Cunha CB; Mylonakis E
    J Glob Antimicrob Resist; 2020 Sep; 22():842-844. PubMed ID: 32763357
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs.
    Vernaz N; Agoritsas T; Calmy A; Gayet-Ageron A; Gold G; Perrier A; Picard F; Prendki V; Reny JL; Samer C; Stirnemann J; Vetter P; Zanella MC; Zekry D; Baggio S
    Swiss Med Wkly; 2020 Dec; 150():w20446. PubMed ID: 33382449
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia.
    Rampino T; Gregorini M; Perotti L; Ferrari F; Pattonieri EF; Grignano MA; Valente M; Garrone A; Islam T; Libetta C; Sepe V; Albertini R; Bruno R; Belliato M
    Blood Purif; 2021; 50(4-5):566-571. PubMed ID: 33181508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Experience in the management of severe COVID-19 patients in an intensive care unit.
    Sosa-García JO; Gutiérrez-Villaseñor AO; García-Briones A; Romero-González JP; Juárez-Hernández E; González-Chon O
    Cir Cir; 2020; 88(5):569-575. PubMed ID: 33064694
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
    Okumuş N; Demirtürk N; Çetinkaya RA; Güner R; Avcı İY; Orhan S; Konya P; Şaylan B; Karalezli A; Yamanel L; Kayaaslan B; Yılmaz G; Savaşçı Ü; Eser F; Taşkın G
    BMC Infect Dis; 2021 May; 21(1):411. PubMed ID: 33947344
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.
    Ramos-Martínez A; Parra-Ramírez LM; Morrás I; Carnevali M; Jiménez-Ibañez L; Rubio-Rivas M; Arnalich F; Beato JL; Monge D; Asín U; Suárez C; Freire SJ; Méndez-Bailón M; Perales I; Loureiro-Amigo J; Gómez-Belda AB; Pesqueira PM; Gómez-Huelgas R; Mella C; Díez-García LF; Fernández-Sola J; González-Ferrer R; Aroza M; Antón-Santos JM; Bermejo CL
    Sci Rep; 2021 Jul; 11(1):13733. PubMed ID: 34215803
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical Features of 154 COVID-19 Patients and the Parameters for the Effective Detection of Pneumonia at the Time of the Initial Diagnosis in Japan.
    Morikawa M; Shinoda M; Ota S; Yoshida Y; Hirouchi T; Shinada K; Sasaki O; Sato T; Kamachi K; Shinkai M
    Intern Med; 2021 Jan; 60(1):31-37. PubMed ID: 33132330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Göpel S; Bethge W; Martus P; Kreth F; Iftner T; Joos S; Döbele S; Mordmüller B; Kremsner P; Ettrich T; Seufferlein T; Bitzer M; Malek N
    Trials; 2020 Jul; 21(1):635. PubMed ID: 32650818
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up.
    Muñoz P; Galar A; Catalán P; Valerio M; Aldamiz-Echevarría T; Cólliga C; Bouza E;
    Rev Esp Quimioter; 2020 Oct; 33(5):369-378. PubMed ID: 32729288
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study.
    Maldonado V; Hernandez-Ramírez C; Oliva-Pérez EA; Sánchez-Martínez CO; Pimentel-González JF; Molina-Sánchez JR; Jiménez-Villalba YZ; Chávez-Alderete J; Loza-Mejía MA
    Int Immunopharmacol; 2021 Jan; 90():107209. PubMed ID: 33278747
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.